627-76-9

Basic information

• Product Name: DL-ALPHA-AMINOPIMELIC ACID
• Synonyms: DL-Heptyline DL-2-aMinoheptanedioic acid;NSC 402480;DL-a-AMinopiMelic acid, H-DL-ApM-OH;DL-a-Aminopimelic acid≥ 99% (TLC);DL-2-AMINOHEPTANEDIOIC ACID;DL-2-AMINOPIMELIC ACID;DL-2-AMINO-1,7-HEPTANEDIOIC ACID;D,L-A-AMINOPIMELIC ACID
• CAS NO: 627-76-9
• Molecular Formula: C₇H₁₃NO₄
• Molecular Weight: 175.18
• EINECS: 211-011-7
• Product Categories: Amino Acids;Amino Acids 13C, 2H, 15N;Amino Acids & Derivatives
• Mol File: 627-76-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 223 °C (dec.)(lit.)
• Boiling Point: 378.5 °C at 760 mmHg
• Flash Point: 182.7 °C
• Appearance: /
• Density: 1.275 g/cm³
• Vapor Pressure: 8.95E-07mmHg at 25°C
• Refractive Index: 1.51
• Storage Temp.: Store at RT.
• Solubility: Methanol (Slightly, Heated), Water (Slightly)
• PKA: 2.52±0.24(Predicted)
• CAS DataBase Reference: DL-ALPHA-AMINOPIMELIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: DL-ALPHA-AMINOPIMELIC ACID(627-76-9)
• EPA Substance Registry System: DL-ALPHA-AMINOPIMELIC ACID(627-76-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 627-76-9(Hazardous Substances Data)

Usage

Chemical Properties

White powder

InChI:InChI=1/C7H13NO4/c8-5(7(11)12)3-1-2-4-6(9)10/h5H,1-4,8H2,(H,9,10)(H,11,12)

Upstream product

• 872807-78-8 1-acetylamino-5-cyano-pentane-1,1,5-tricarboxylic acid triethyl ester 
• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 
• 53279-89-3 7,7-dichloro-hept-6-enoic acid 
• 5462-80-6 rac-6-hydroxynorleucine 
• 17126-90-8 2-oxoheptane-1,7-dioate 
• 32245-65-1 (D,L)-Cbz-ε-hydroxynorleucine 
• 32097-48-6 Aethyl 2-Benzyloxycarbonylamino-6-hydroxyhexanoat 
• 7647-01-0 hydrogenchloride 
• 32097-51-1 N-Benzyloxycarbonylamino-6-cyanohexanosaeure 
• 16714-79-7 2-chloro-heptanedioic acid 
• 110-52-1 1,4-dibromo-butane 
• 5680-61-5 diethyl 2-phthalimidomalonate 

Downstream Products

• 70-54-2 2,6-diaminocaproic acid 
• 98839-17-9 N-(benzyloxycarbonyl)-L-alanyl-L-alanyl-DL-2-aminopimelic acid 
• 70650-83-8 2-(4-amino-benzoylamino)-heptanedioic acid 
• 70539-44-5 2-(4-Nitro-benzoylamino)-heptanedioic acid 
• 38167-88-3 7-carboethoxy-tetrahydro-2(3H)-azepinone 
• 911437-73-5 (+/-)-6-hydroxy-6-phenylcarbamoyl hexanoic acid methyl ester 
• 911437-74-6 (+/-)-7-hydroxy-7-phenylcarbamoylheptanoic acid methyl ester 
• 911437-75-7 (+/-)-8-hydroxy-8-phenylcarbamoyl octanoic acid methyl ester 
• 911437-76-8 (+/-)-6-(4-methoxybenzyloxy)-6-phenylcarbamoyl hexanoic acid methyl ester 
• 911437-77-9 (+/-)-7-(4-methoxybenzyloxy)-7-phenylcarbamoyl heptanoic acid methyl ester 
• 911437-78-0 (+/-)-8-(4-methoxy-benzyloxy)-8-phenylcarbamoyloctanoic acid methyl ester 
• 960012-74-2 (+/-)-7-hydroxy-7-(4-methoxyphenylcarbamoyl)heptanoic acid methyl ester 

Relevant articles and documents

GADD45BETA TARGETING AGENTS

Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.

PREPARATION OF 6-AMINOCAPROIC ACID FROM α-KETOPIMELIC ACID

The invention relates to a method for preparing 6-aminocaproic acid (hereinafter also referred to as '6-ACA')usinga biocatalyst. The invention further relates to a method for preparing e-caprolactam (hereafter referred to as 'caprolactam') by cyclising such 6-ACA. The invention further relates to a host cell, a micro-organism, or a polynucleotidewhich may be used inthe preparation of 6-ACA or caprolactam.

Peptides with an insulin-like action

Peptides with an insulin-like action, of formula I: STR1 in which G is a hydrogen atom, an amino add residue, or a monosubstituted or polysubstituted amino acid; D is an amino acid residue, a phosphoamino acid residue, a monosaccharide residue, or a covalent bond; E is --NH--(CH2)n --NR52, a glycerol residue, or --NH--(CH2)p --R6 --R7 ; R1 is (C1 -C4)-alkyl or =O; R2 is a sulfhydryl protecting group, (C1 -C3)-alkyl, or a hydrogen atom; R3 and R4, independently of one another, are a hydrogen atom or methyl; R5, each being identical or different, is a hydrogen atom, 1 to 6 monosaccharide residues, or 1 to 6 monosubstituted or polysubstituted monosaccharide residues; R6 is O PO4 H, PO2 H, NHCOO, S or OCOO; R7 is a hydrogen atom, 1 to 6 monosaccharide residues, or 1 to 6 monosubstituted or polysubstituted monosaccharide residues; w is an integer 1 or 2; their preparation and use for treatment of diabetes mellitus or insulin-independent diabetes.